Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors

• Váldodahkkit: Robert Knoerl (Dahkki), Emanuele Mazzola (Dahkki), Sandra A. Mitchell (Dahkki), Fangxin Hong (Dahkki), Elahe Salehi (Dahkki), Nadine McCleary (Dahkki), Jennifer A. Ligibel (Dahkki), Kaitlen Reyes (Dahkki), Donna L. Berry (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SpringerOpen, 2021-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Timely detection of chemotherapy-induced peripheral neuropathy (CIPN) is critical to effectively tailor chemotherapy dose levels and offer supportive care. The purpose of this secondary analysis was to determine the reliability and validity of the two Patient-Reported Outcomes Ve...